Case Overview

| | |

|---|---|

| Article Type | Product Recall / Defective Products Roundup |

| Vertical | Class Action — Defective Products |

| Published | March 2026 |

Defective Products Roundup: Andersen Windows Recall and Consumer Safety Cases to Know in March 2026

A major window safety recall is drawing attention this month as Andersen Windows moves to pull nearly 100,000 potentially hazardous devices from homes across the country. For consumers who own affected products, understanding what's being recalled — and what remedies may be available — is an important first step.

This month's roundup focuses on the Andersen Windows recall and the broader consumer product safety landscape, as regulators and courts continue addressing defective goods that may pose risks to everyday users.

1. Andersen Windows Opening Control Device Recall

Recall Announced: March 2026

Products Affected: Approximately 91,000 window opening control devices

Hazard: Potential fall and injury risk

Who May Be Affected: Consumers who purchased and installed Andersen window opening control devices

According to a recent report on the recall, Andersen Windows is recalling approximately 91,000 window opening control devices due to potential fall and injury hazards. The recall suggests that the devices — which are designed to limit how far a window can open, often as a child safety measure — may fail to perform as intended, potentially creating a dangerous gap that could allow a fall.

Window opening control devices are commonly installed in residential settings, particularly in upper-floor windows where falls pose a serious risk to children and vulnerable adults. A device that fails to restrict window travel adequately could defeat the primary purpose for which it was purchased.

Consumers who believe they may have affected devices installed in their homes should consult the official recall notice for specific product identification information, model numbers, and guidance on next steps. Recall remedies may include free replacement parts or repairs, though consumers should verify the details directly through Andersen or the U.S. Consumer Product Safety Commission (CPSC).

How to find recall information: Visit the CPSC recalls database and search "Andersen Windows" for the official recall notice and instructions.

2. Website Pixel Tracking and Healthcare Privacy Litigation

Case Status: Active federal litigation

Jurisdiction: District of Massachusetts (and other federal courts)

Who May Be Affected: Patients who used healthcare provider websites with embedded tracking technologies

Federal courts continue to grapple with a wave of lawsuits alleging that healthcare providers and hospital systems embedded third-party pixel tracking technologies — such as those used by advertising platforms — on patient-facing websites, potentially capturing sensitive health information without proper authorization.

In one recent decision, Progin v. UMass Memorial Health Care, Inc., a Massachusetts federal court weighed claims brought under the federal Wiretap Act. The plaintiffs alleged that the defendant healthcare entities used pixel technologies that intercepted user communications in violation of federal wiretapping law. The court applied what legal observers have described as a "heightened intent requirement" for satisfying the crime-tort exception under the Wiretap Act, a standard that has proven difficult for plaintiffs to meet in multiple recent rulings.

While this particular ruling narrowed one legal avenue for plaintiffs, litigation over healthcare website tracking technologies remains active across the country, with cases proceeding on various legal theories including state privacy laws and HIPAA-related claims.

Individuals who used healthcare provider websites and are concerned about how their data may have been handled may wish to monitor developments in this area of litigation.

How to stay informed: Court filings in federal cases are publicly available through PACER, the federal courts' electronic records system.

3. SPAC-Era Litigation: Statute of Limitations Battles Continue

Case Status: Active federal litigation

Period at Issue: 2020–2022 SPAC transactions

Who May Be Affected: Investors who participated in SPAC mergers and related securities offerings during the 2020–2022 period

Several years after the peak of the Special Purpose Acquisition Company (SPAC) boom, litigation stemming from that era continues to move through the federal court system. Investors who allege they were harmed by inflated projections, inadequate disclosures, or other issues connected to de-SPAC transactions — the mergers through which SPAC shells combined with operating companies — are still pursuing claims in court.

A key legal question in ongoing cases involves when the applicable statute of limitations begins to run. In a February 2026 ruling, at least one federal court addressed whether the three-year limitations period for certain securities claims starts from the date of the SPAC transaction itself or from a later point when alleged misstatements became apparent to investors. The outcome of these accrual disputes could significantly affect whether investor claims survive long enough to reach trial or settlement.

For investors who participated in SPAC transactions during the 2020–2022 period and believe they suffered losses, the statute of limitations question is a time-sensitive legal consideration. Those with potential claims may wish to consult with a securities attorney to understand whether applicable deadlines apply to their situation.

How to stay informed: Public court dockets for federal securities cases can be searched through PACER.

Key Takeaways

• The Andersen Windows recall affects approximately 91,000 devices — consumers with window opening control devices from Andersen should verify whether their products are included and review available remedy options through the CPSC or the manufacturer directly.
• Healthcare pixel tracking lawsuits face mixed results in federal court — while some claims have been dismissed on Wiretap Act grounds, litigation continues under other legal theories, and affected patients should monitor developments.
• SPAC-era investor claims remain active — statute of limitations disputes could determine whether older investor claims survive, making timing a critical factor for anyone considering legal consultation.
• Recalls don't automatically create class action lawsuits — a product recall is a manufacturer or regulatory action; separate litigation may or may not follow.
• Proof of purchase requirements vary — in many consumer product recall situations, registration records or purchase history may help establish eligibility for remedies.

Have questions about any of the cases or recalls featured in this roundup? Share your thoughts or experiences in the comments below.

InjuryClaims.com reports on class action lawsuits, settlements, and consumer safety news. Nothing in this article constitutes legal advice. Readers with specific legal questions should consult a licensed attorney.